Dr. Sylvestre is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
520 27th St
Oakland, CA 94612Phone+1 510-834-5442Fax+1 510-834-0916
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 1988 - 1990
Harvard Medical SchoolClass of 1988
Certifications & Licensure
CA State Medical License 1995 - 2025
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Buprenorphine and Integrated HIV Care Evaluation Start of enrollment: 2005 Aug 01
- A Video-Based HCV Curriculum for Drug Users Start of enrollment: 2005 Nov 01
- Integrating Buprenorphine Into HIV Treatment Start of enrollment: 2005 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- 39 citationsCannabis use improves retention and virological outcomes in patients treated for hepatitis CDiana L. Sylvestre, Barry J. Clements, Yvonne Malibu
European Journal of Gastroenterology & Hepatology. 2006-10-01 - 158 citationsTreating hepatitis C in methadone maintenance patients: an interim analysis.Diana L. Sylvestre
Drug and Alcohol Dependence. 2002-07-01 - 17 citationsEducation by peers is the key to successLarry Galindo, Tim Maginnis, Gerard Wallace, Andy Hansen, Diana L. Sylvestre
The International Journal on Drug Policy. 2007-10-01
Press Mentions
Treating the New Hep C Generation on Their TurfDecember 7th, 2017
The Face of Hepatitis C Is Getting YoungerDecember 1st, 2017
Hepatitis C, a Silent Killer, Meets Its MatchNovember 4th, 2013
Grant Support
- HCV Treatment Of Idus After Buprenorphine StabilizationNational Institute On Drug Abuse2002–2004
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
